A healthcare provider says Bristol Myers Squibb overcharged for Thalidomide and Revlimid after paying erstwhile generic competitors to delay entry until January 2026 or later.
The maker of two ophthalmic lubricant gels is accused of misleading consumers by marketing its eye drops as “sterile” without ensuring the products were free from potentially infection-causing bacteria and fungi.
The maker of two ophthalmic lubricant gels is accused of misleading consumers by marketing its eye drops as “sterile” without ensuring the products were free from potentially infection-causing bacteria and fungi.
The NBA argues the federal appeals court is bound by circuit precedent to carve out this type of Meta Pixel data disclosure case from civil claims under the 1988 Video Privacy Protection Act.
The digital theft and copying of hundreds of thousands of copyrighted articles to train AI apps like ChatGPT is a “death knell” for the already fragile local journalism industry, the publishers say.
New York City's largest police union says a public watchdog's release of unsubstantiated misconduct claims causes irreparable damage to officers' professional reputations and long-term career prospects.
Regeneron executives touted its cancer treatment as a “potential blockbuster,” as clinical trial results did not find the drug combination as effective as publicized.
Investors say EquipmentShare failed to disclose related-party transactions that reportedly benefited companies linked to its founders to the tune of some $77 million.
Consumers continued paying higher fuel prices in the month of July as the war in Iran, now entering its sixth month, still hinders global fuel shipments.
